Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-specific killing activity. Here we show that pyocin L1, a novel member of this family from <i>Pseudomonas aeruginosa</i>, targets susceptible strains of this species through recognition of the common polysaccharide antigen (CPA) of <i>P. aeruginosa</i> lipopolysaccharide that is predominantly a homopolymer of d-rhamnose. Structural and biophysical analyses show that recognition of CPA occurs through the C-terminal carbohydrate-binding domain of pyocin L1 and that this interaction is a prerequisite for bactericidal activity. Further to this, we show that the previously described lectin-like bacteriocin putidacin L1 shows a s...
Bacterial biofilms represent a challenge to the healthcare system because of their resilience agains...
Bacteria produce a diverse array of antagonistic compounds to restrict growth of microbial rivals. C...
Pseudomonas aeruginosa is a priority pathogen for the development of new antibiotics, particularly b...
Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-speci...
<div><p>Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a gen...
Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-speci...
Lectin-like bacteriocins are antibacterial proteins constituted of two structurally similar monocot ...
Lectin-like bacteriocins of the LlpA family, originally identified in plant-associated bacteria, are...
Pseudomonas is a metabolically versatile genus that has acquired several antagonism-mediating mechan...
Bacteriocins are secreted bacterial proteins that selectively kill related strains. Lectin-like bact...
Pseudomonads are equipped with an arsenal of antagonism-mediating molecules to gain hold in competit...
Soil bacteria produce a plethora of antibacterial compounds that enable them to gain hold in nutrien...
ABSTRACT Lectin-like bacteriocins (LlpAs) are secreted by proteobacteria and selectively kill strain...
The LlpA protein from Pseudomonas putida represents the prototype of a novel family of antimicrobial...
Pseudomonas aeruginosa produces three different types of bacteriocins: the soluble S-pyocins and the...
Bacterial biofilms represent a challenge to the healthcare system because of their resilience agains...
Bacteria produce a diverse array of antagonistic compounds to restrict growth of microbial rivals. C...
Pseudomonas aeruginosa is a priority pathogen for the development of new antibiotics, particularly b...
Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-speci...
<div><p>Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a gen...
Lectin-like bacteriocins consist of tandem monocot mannose-binding domains and display a genus-speci...
Lectin-like bacteriocins are antibacterial proteins constituted of two structurally similar monocot ...
Lectin-like bacteriocins of the LlpA family, originally identified in plant-associated bacteria, are...
Pseudomonas is a metabolically versatile genus that has acquired several antagonism-mediating mechan...
Bacteriocins are secreted bacterial proteins that selectively kill related strains. Lectin-like bact...
Pseudomonads are equipped with an arsenal of antagonism-mediating molecules to gain hold in competit...
Soil bacteria produce a plethora of antibacterial compounds that enable them to gain hold in nutrien...
ABSTRACT Lectin-like bacteriocins (LlpAs) are secreted by proteobacteria and selectively kill strain...
The LlpA protein from Pseudomonas putida represents the prototype of a novel family of antimicrobial...
Pseudomonas aeruginosa produces three different types of bacteriocins: the soluble S-pyocins and the...
Bacterial biofilms represent a challenge to the healthcare system because of their resilience agains...
Bacteria produce a diverse array of antagonistic compounds to restrict growth of microbial rivals. C...
Pseudomonas aeruginosa is a priority pathogen for the development of new antibiotics, particularly b...